EUVIMEDEUVIMED entdecken
Crossref

Differences in arteriovenous carboxyhemoglobin in neonates with noninflammatory pulmonary diseases

Toshihiko Nakamura iD, Daisuke Hatanaka, Eisuke Fukama iD

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 19.06.2025. Verfasst von Toshihiko Nakamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Japanese Red Cross Musashino Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Carboxyhemoglobin, Lung Diseases. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To retrospectively examine whether differences in arteriovenous carboxyhemoglobin (a‐vCOHb) can be used as a marker for evaluating the severity of neonatal lung disease that develops soon after birth.

Methods

The subjects were 129 newborn neonates who were classified into three groups comprising 48 infants with severe respiratory disorder (group S), 46 with mild‐to‐moderate respiratory disorder (group M), and 35 in a control group without respiratory disorder (group C). Various parameters including COHb were measured using a blood gas analyzer/oximeter at the time of admission, with sampling of arteries and veins performed at short intervals (within 30 min).

Results

The arterial COHb values were significantly higher in group C than in group S. The a‐vCOHb values were significantly higher in groups C and M than in group S. This suggested that a loss of carbon monoxide excretion due to the generation of shunt blood with lung collapse at the alveolar level and a decrease in the total amount of carbon monoxide generated within the lungs resulted in the decrease of a‐vCOHb values in group S. Receiver operating characteristic curve analysis of a‐vCOHb for predicting the need for respiratory support identified an a‐vCOHb cut‐off value of 0.3% with a sensitivity of 75% and specificity of 74% ( p < 0.001).

Conclusion

An a‐vCOHb cut‐off value of 0.3% may be useful in determining the severity of lung disease in the early neonatal period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarboxyhemoglobinLung DiseasesHumansInfant, NewbornRetrospective StudiesMaleFemaleBiomarkersSeverity of Illness IndexROC CurveBlood Gas AnalysisOximetry

Stichwörter der Autor:innen

carbon monoxidecarboxyhemoglobinheme oxygenaseneonatespulmonary disease

Substanzen

CarboxyhemoglobinBiomarkers

Autor:innen und Institutionen

  • Department of Neonatology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

ORCID-Profile: Toshihiko Nakamura, Eisuke Fukama

Zitieren

APA

Nakamura, T., Hatanaka, D., & Fukama, E. (2025). Differences in arteriovenous carboxyhemoglobin in neonates with noninflammatory pulmonary diseases. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70117

Vancouver

Nakamura T, Hatanaka D, Fukama E. Differences in arteriovenous carboxyhemoglobin in neonates with noninflammatory pulmonary diseases. Pediatrics International. 2025;67(1). doi:10.1111/ped.70117

BibTeX
@article{Nakamura2025,
  author = {Nakamura, Toshihiko and Hatanaka, Daisuke and Fukama, Eisuke},
  title = {Differences in arteriovenous carboxyhemoglobin in neonates with noninflammatory pulmonary diseases},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70117}
}
Kostenlos starten →